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ABSTRACT
Objective: To determine the prevalence of acute coronary syndromes among type 2 
diabetic patients presenting to Accident and Emergency department. 
Design: Prospective cross-sectional study. 
Setting: Kenyatta National Hospital, a tertiary teaching and referral hospital. 
Subjects: Type 2 diabetic patients with ischaemic electrocardiograms (ECG). 
Main outcome measures: Demographics, clinical symptoms, cardiovascular status and 
risk factors - central obesity, hypertension, dyslipidaemia, smoking. 
Results: From 12,307 accident and emergency attendees, 400 ( 33%) diabetics aged 
>30 years were screened with a resting ECG and 95 (24%) with ischaemic ECG were 
recruited; age range 41-87 years, 60% were male; diabetes duration ranged 0-30 years 
with 8.4% being newly diagnosed. The commonest enrolling ECG feature was non-
specific ST-T changes. The commonest presenting complaint were fatigue and dyspnoea. 
Majority had three coronary artery disease (CAD) risk factors: obesity 86%, elevated 
LDL 73% and hypertension 60%. Therapy in use was OHA 43%, insulin 42%, insulin 
and OHA 1%; prophylactic aspirin 14.7% and statins 8.4%. Thirty four (35.8%) were 
classified as acute coronary syndrome (ACS); 29 ( 30.5%) acute myocardial infarction 
(ACS-AMI) and five (5.2%) unstable angina (ACS-UA). Majority (79.4%) of the ACS 
presented more than six hours after symptom onset and majority had features of acute 
left ventricular failure. 
Conclusions: Acute coronary syndrome accounted for 35% of the morbidity in type 2 
diabetics with ischaemic ECG’s presenting to KNH accident and emergency department; 
patients presented late and 80% were not on CAD prophylactic therapy. 
INTRODUCTION 
The global number of individuals with diabetes is 
projected to increase markedly from 171 million 
(2.8% of the world’s population) in 2000 to 366 
million (6.5%) in 2030; 298 million of whom, will 
live in developing countries (1). Cardiovascular 
disease, with its attendant morbidity and mortality, 
particularly in the diabetic population, is on the rise in 
the developing countries (2) with mortality expected 
to increase from an estimated 9 million in 1990 to 19 
million by 2020 (3). 
 Coronary artery disease (CAD) is a major cause 
of morbidity and mortality amongst patients with 
diabetes mellitus. Several studies have shown that 
compared to non-diabetics, diabetics have a higher 
prevalence of CAD, a greater extent of coronary 
ischaemia, and are more likely to have acute 
myocardial infarction (AMI), and silent myocardial 
ischaemia (4 – 6). 
 Coronary artery disease is a growing epidemic 
on the African continent, on account of the increasing 
prevalence of the classical risk factors for CAD, with a 
regularly reported concurrence of multiple risk factors 
in the same individual (7). In the INTERHEART Africa 
study (8), history of smoking, diabetes, hypertension, 
abdominal obesity, and ratio of apolipoprotein B 
to apolipoprotein A-1 provided for a population 
attributable risk of 89.2% for AMI. Non-specific ST-
T wave ECG changes has also been shown to have 
CAD prediction power and can be considered as a 
risk factor (9). 
 In observational studies of CAD in diabetes, 
incidence rates of AMI have varied widely mainly as 
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a function of ethnic background, inclusion criteria, 
definition of end points, and duration of follow-up 
(10-12). There is limited local data on the prevalence 
and presenting characteristics of ACS amongst the 
diabetics in our population. 
 Consequently, the aim of this study was 
to determine the prevalence and presenting 
characteristics of acute coronary syndromes amongst 
type 2 diabetics with ischaemic ECG’s. 
MATERIALS AND METHODS 
During the period of July 2007 to October 2007 
all type 2 diabetic patients, with a prior chart 
diagnosis/treatment or A&E newly diagnosed and 
aged >30 years, presenting to the Kenyatta National 
Hospital and Emergency Department (KNH A&E) 
with medical complaints were screened with a 12 
lead resting ECG using a standardised portable 
machine. Those with ECG features of ischaemia were 
consecutively recruited and underwent a thorough 
clinical evaluation including weight, waist and hip 
circumferences and blood drawn for measurement of 
serial serum Troponin I and fasting lipid levels. 
 Ischaemia ECG features were defined as follows: 
Abnormal Q waves: any Q waves in leads V1 to V3 
or Q wave > 30m sec in leads I, II, aVL, aVF, or V4 
- V6; present in any two contiguous leads and > 1 
mm in depth. ST elevation: 1 mm from the baseline 
measured at 0.08 seconds from the J point, in at least 
two contiguous precordial leads or in at least two 
adjacent limb leads. ST depression not associated 
with ventricular hypertrophy: horizontal, down 
sloping or up sloping depression at >1 mm from the 
baseline measured at 0.08 seconds from the J point. 
T wave inversion not associated with ventricular 
hypertrophy and Left Bundle Branch Block by 
standard conventional criteria (13). 
 Patients were classified as hypertensive on basis of 
a chart diagnosis or treatment for hypertension. Newly 
diagnosed patients were diagnosed on the basis of JNC 
7 criteria by the attending A&E physician. Cigarette 
smoking status was classified as either current smoker: 
last smoked within the past one year or non - smoker: 
last smoked more than a year ago or had never smoked. 
A positive family history of CAD was defined as CAD 
in a first degree relative occurring before age of 60 
years (14). Waist circumference was measured in cm, 
in the horizontal plane, at the level of the narrowest 
part of the torso between the lowest rib and the top of 
the pelvis, as seen from the anterior view, at the end 
of a normal expiration (15). A measured value of > 
102cm in males and > 88 cm in females was classified 
as Central obesity as defined by NCEP/ATPIII (16). 
The hip circumference was measured in centimeters, as 
the maximum circumference at the level of the greater 
trochanters in the horizontal plane (17). The Waist Hip 
Ratio was calculated as the ratio of the former to the 
latter and defined by WHO criteria as abnormal if the 
ratio was >0.90 in males and >0.85 in females (18). 
 Two mililiters of blood was drawn for 
measurement of serum Troponin I and if the initial 
level was normal, a second sample was drawn 8 hours 
later. The samples were assayed by a dedicated study 
technician at the KNH laboratory with the Minividas 
Troponin I kit by HASS Ltd. Serum Troponin I 
levels > 0.01 ng/ml were considered elevated and 
therefore diagnostic of an acute myocardial infarction, 
representing the 99th percentile value for the kit utilised 
(13). Two mls of blood was drawn after an 8 hour fast 
for fasting lipid levels. The samples were assayed by 
a dedicated study technician at the Department of 
Internal Medicine laboratory, University of Nairobi 
with the Human kits by HUMAN Ltd. According to 
the NCEP/ATP III guidelines (16), the following levels 
were considered abnormal: HDL-C < 1.03 mmol/I (for 
both genders); Triglycerides > 1.7 mmolll and LDL-C 
> 1.8 mmol/l. 
 Study patients were classified as ACS or 
Non-ACS on basis of the following criteria; Acute 
myocardial infarction: elevated serum Troponin 
I; unstable angina: normal serum Troponin I with 
concurrent angina; Non-ACS: normal serum Troponin 
I without concurrent angina or angina equivalent 
dyspnoea. 
 The study was approved by the KNH ethics 
committee. Data was analysed with SPSS version 15.0 
software. Continuous data was analysed into means 
and categorical data were analysed into percentages 
with the corresponding 95% confidence intervals. 
Prevalence rates were calculated similarly. Statistical 
significance was defined as a two tailed p-value of 
less than or equal to 0.05. 
RESULTS 
Over a four month period between 1st July 2007 to 
31st October 2007,12,307 medical case patients were 
attended to at Kenyatta National Hospital Accident 
and Emergency Department (KNH A&E), 400 (33%) 
of whom were diabetics aged over 30 years. The latter 
group comprised our study target population and 
were consecutively screened with an index resting 12 
lead ECG; 95 (24%) were classified as ischaemic ECG 
and were recruited. Over the study recruitment period 
the numbers screened and proportion recruited on a 
weekly basis did not vary considerably; with a weekly 
average of 22 individuals screened and 22% recruited. 
(Figure 1). Age ranged from 41-87 years with a mean 
age of 63.3 years; 60% were male; 56% were either 
retired of unemployed; 58% had attained primary 
level of education whereas only 42% had attained 
secondary or above level of education. Minority of 
the patients were newly diagnosed diabetics (8.4%); 
diabetic disease duration ranged from 0-30 years with 
a mean of 11 years. 
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Enrollment qualifying EGG included 41% T wave 
inversion, 18% ST depression and 15% with LBBB. 
Ten patients had ST elevation and mixed features each 
and five patients demonstrated abnormal Q waves. 
Nine patients were in atrial fibrillation and the rest 
in normal sinus rhythm. (Table1) 
Figure 1
Weekly screening and recruitment of diabetic patients  
Table 1
ECG characteristics of the study population 
ECG feature No. (%) 
Defining Criteria - Ischaemic ECG features 
    T wave inversion in absence of LVH 39 41.1 
    ST depression 17 17.9 
    Left Bundle Branch Block 14 14.7 
    ST elevation 10 10.5 
    Multiple ischaemic features 10 10.5 
    Abnormal Q waves 5 5.3 
Cardiac rhythm   
    Sinus rhythm 86 90.5 
    Atrial fibrillation 9 9.5  
The commonest A&E presenting complaint was 
exertional dyspnoea in 51.6 % ; 30.5% were in NYHA 
Class III/IV; rest angina 16.8%, epigastric pain 12.6% 
and cerebrovascular accident 4.2% (Figure 2). All 
patients had at least one other cardiovascular risk 
factor, with the majority having more than three 
factors; Obesity by WHR 86%, elevated LDL 73% 
obesity by waist circumference (WC) 62% and 
hypertension 60%. Cigarette smoking was infrequent 
at 8.4% as was prior MI and family history both at 
1%. ( Figure 3). Median and range lipid values were 
total cholesterol 4.5 (1.4-10.5) mmol/I, LDL-C 2.4 
(0.5-9.4) mmol/l, HDL 0.9 ( 0.1-2.4) mmol/I and 
triglycerides 1.1 ( 0.2-7.7) mmol/1. Dyslipidaemia 
was documented in 95%; 73% elevated LDL-C, 54.7% 
depressed HDL and 30% elevated triglycerides 
(TGs); 51.6% had only one lipid abnormality; 36.8% 
had two abnormalities while 6.3% had all three lipid 
abnormalities (Figure 5). Most women (97%) were 
postmenopausal and all smokers were male. Women 
were more likely to be classified as obese on basis 
of the WC (male 43.9%; female 89.5%,   p - 0.001); 
whereas on the basis of WHR obesity was equally 
distributed among the genders. 
      Screened patient        Recruited patients
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Cardiovascular  risk factors in the study population 
(n=95)
Figure 4
Flow chart of patients in study
Figure 2
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Figure 5
Occurrence of combinations of elevated LDLC/low 
HDLC and elevated triglycerides
There was no statistically significant difference 
between the male and female patients with regard 
to the prevalence of hypertension (p = 0.4), central 
obesity as defined by waist-hip ratio (p = 0.6) and 
elevated LDL - Cholesterol (p = 0.6). 
 Anti-diabetic therapy utilised prior to A&E 
presentation included oral hypoglycaemic agents 
(OHA) in 43%, insulin 42%, insulin and OHA 1% 
and dietary control in 5.3%. Only 14.7% and 8A% of 
the patients in the study population were on aspirin 
and statins therapy respectively. 
 On the basis of clinical presentation and 
Troponin assays 34 (35.8%) participants were 
classified as having an acute coronary syndrome 
(ACS); 29 (30.5%) acute myocardial infarction (ACS-
AMI), five (5.2%) unstable angina (ACS-UA) and 61 
(64.2%) as non-ACS presentations. (Figure 4).The 
most common symptoms amongst the patients 
with ACS were breathing difficulty and fatigue; 
47% presented with typical angina whereas 52.9% 
had atypical symptoms. Majority (79.4%) of ACS 
patients presented to the A&E six hours or more after 
onset of symptoms; the mean duration of symptoms 
being 5.5 days and majority had features of acute 
left ventricular failure (Figure 6). 
Figure 6
Cardiovascular status of patients with acute myocordial 
infarction
 No statistically significant difference was 
evident between patients with and without acute 







































duration of diabetes or cardiovascular risk factors; 
the only exception being hypertension which 
was more prevalent in those with acute coronary 
syndromes(79.4%; 49.2%; p = 0.004). 
DISCUSSION 
Our findings demonstrate that type 2 diabetics 
comprise 3% of all medical A&E attendees, over a 
six month period, at this tertiary referral facility that 
also serves as a primary care emergency facility for 
the majority of the population of the city of Nairobi 
and its environs, with an estimated population of 3-4 
million inhabitants. This is a significant proportion and 
is consistent with records at this facility and we believe 
the study reflects the rising prevalence of type 2 diabetes 
in our urban and peri-urban populations, for which 
no comprehensive data exists. By design we opted 
for the age entry criteria of 30 years to predominantly 
capture a sample of type 2 diabetes, which we have 
reason to believe was indeed the case. 
 A quarter of these diabetic patients demonstrated 
study designated ischaemic changes in their resting 
EGG; with the majority showing non-specific ST-T wave 
changes. A  minority showed ECG evidence of on-going 
ischaemia, with ST elevation and  presumably new LBBB 
pattern; and atrial fibrillation. This high frequency of 
ischaemic ECG changes is compatible with the high 
cardiovascular risk profile of the study sample, as 
demonstrated by their demographics, diabetic vascular 
age and high prevalence of multiple cardiovascular 
risk factors. We selected non-specific ischaemic ECG 
changes as a marker for high CAD risk patient group. 
 A similar high risk profile has been demonstrated 
in recent studies on type 2 diabetics attending 
the institution’s out-patient diabetic clinics (19). 
Despite being at high CHD risk, inclusive of 
significant dyslipidaemia, and the practice guideline 
recommendations of intensive risk reduction 
treatment for such patients, the use of statins and 
mandatory anti-platelet therapy was abysmal. The 
reasons for this are probably multi-factorial and 
warrant further study and urgent intervention, in 
particular regard to the inexpensive and readily 
accessible acetylsalicylic acid (ASA) therapy. 
 Consequently a third of these patients were 
classified as having an ongoing acute coronary syndrome 
(AGS), on the basis of clinical profile and elevated 
Troponin assay. This proportion contrast sharply with 
departmental records, reviewed and compiled as part 
of the planning stage of this study, which suggested a 
7.3% four month period prevalence (July- October 2006) 
of AMI in type 2 diabetic attending the A&E. Despite 
acknowledging the potential incompleteness of routine 
data, this discrepancy in prevalence suggests that up 
to two thirds of such patients are being miss-classified 
as non-ACS at A&E presentation evaluation, leading 
to potential delayed life saving interventions and 
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for favorable outcomes.  An important observation is 
the late and atypical mode of presentation of our ACS 
in diabetics. Possible reasons for this include the DM 
associated sensory neuropathy, failure by patients and 
primary health care workers to recognise the  implication 
of symptoms and inaccessibility to health care; these 
factors can be potentially overcome by comprehensive 
health education. 
 Our data is limited by the potential for type 2 
diabetes misclassification bias and tertiary facility 
referral bias. The performance of C-peptide and IIlet 
cell antibodies studies were unavailable to minimise 
the latter however, the age range of our sample of 40-87 
years and the mean duration of diabetes of 11 years, we 
believe make the contribution of this bias as nominal. 
None of our study cases were hospital transfers however 
the poor haemodynamic profile of cases should be seen 
in the light of this inherent referral bias. 
In conclusion we have demonstrated that ACS are 
not infrequent among type 2 diabetics presenting to 
our A&E department and that we need to increase 
vigilance among our staff by imploring a high index 
of suspicion, given the high risk profile and atypical 
and varied presentation profile of our patients. We 
recommend that all diabetics attending our A&E 
should undergo a screening ECG evaluation as part 
of their workup along with a myocardial cell death 
marker depending on the clinical profile. 
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